Bauldry S A, Wooten R E
Pulmonary and Critical Care Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157, U.S.A.
Biochem J. 1997 Mar 1;322 ( Pt 2)(Pt 2):353-63. doi: 10.1042/bj3220353.
Relationships between phospholipases are poorly understood, but phosphatidic acid (PA) and diglycerides (DGs), produced by phospholipase D (PLD) and phosphatidate phosphohydrolase actions, might function as second messengers coupling cell stimulation to cellular responses. This study investigates the role of PLD-mediated PA and DG formation in inducing phospholipase A2 (PLA2) activity in intact human neutrophils (PMNs) and in PMNs permeabilized with Staphylococcus aureus alpha-toxin. PMNs were labelled with [3H]arachidonic acid (AA) to assess AA release and metabolism and diacylglycerol formation, or with [3H]1-O-hexadecyl-2-lyso-glycerophosphatidylcholine for the determination of platelet-activating factor (PAF), PA and alkylacylglycerol production. In intact PMNs primed with tumour necrosis factor alpha before stimulation with N-formyl-Met-Leu-Phe, AA release and metabolism and PAF formation increased in parallel with enhanced PA and DG formation, and inhibition of PA and DG production led to a decrease in both AA release and PAF accumulation. In alpha-toxin-permeabilized PMNs, AA release and PAF production result from the specific activation of cytosolic PLA2 (cPLA2). In this system, PA and DG formation were always present when cPLA2 activation occurred; blocking PA and DG production inhibited AA release and PAF accumulation. Adding either PA or DG back to permeabilized cells (with endogenous PA and DG formation blocked) led to a partial restoration of AA release and PAF formation; a combination of PA and DGs reconstituted full cPLA2 activity. These results strongly suggest that products of PLD participate in activating cPLA2 in PMNs.
磷脂酶之间的关系目前还了解甚少,但由磷脂酶D(PLD)和磷脂酸磷酸水解酶作用产生的磷脂酸(PA)和甘油二酯(DGs)可能作为第二信使,将细胞刺激与细胞反应偶联起来。本研究调查了PLD介导的PA和DG形成在诱导完整人中性粒细胞(PMN)和经金黄色葡萄球菌α-毒素通透处理的PMN中磷脂酶A2(PLA2)活性方面的作用。PMN用[3H]花生四烯酸(AA)标记以评估AA释放、代谢和二酰甘油形成,或用[3H]1-O-十六烷基-2-溶血甘油磷脂酰胆碱来测定血小板活化因子(PAF)、PA和烷基酰基甘油的产生。在用N-甲酰甲硫氨酸亮苯肽刺激之前用肿瘤坏死因子α预处理的完整PMN中,AA释放、代谢和PAF形成与PA和DG形成的增强平行增加,并且抑制PA和DG产生导致AA释放和PAF积累均减少。在经α-毒素通透处理的PMN中,AA释放和PAF产生是由胞质型PLA2(cPLA2)的特异性激活引起的。在该系统中,当cPLA2激活发生时,PA和DG形成总是存在;阻断PA和DG产生会抑制AA释放和PAF积累。将PA或DG添加回通透处理的细胞(内源性PA和DG形成被阻断)会导致AA释放和PAF形成部分恢复;PA和DGs的组合可重建完整的cPLA2活性。这些结果强烈表明PLD的产物参与激活PMN中的cPLA2。